Predictmedix AI Inc PMEDF

Primary Symbol: C.PMED

Predictmedix AI Inc. is a life sciences technology company. The Company, through its subsidiaries, focuses on artificial intelligence (AI) technologies which target two specific areas: workplace health and safety and healthcare. It has developed a technology for the identification and detection of infectious disease symptoms, including COVID-19, referred to as its infectious disease symptom screening solutions (IDSS) and marketed in North America under the name Safe Entry System. It is also developing AI-powered products that address detection of alcohol and/or cannabis impairment in individuals; mental illness screening, and remote patient monitoring and treatment plans, referred to as the Mobile Wellbeing product. It is adding additional modules to this Mobile Wellbeing platform that enable us to use a patient’s history and real-time medical data, such as blood pressure, and to provide patients and their medical professionals with treatment plans for chronic disease management.

CSE:PMED - Post by User

Predictmedix AI Inc > PMED vs SONA

<< Previous

Bullboard Posts

Next >>

Comment by badog222on Dec 01, 2020 8:47am

110 Views

Post# 32007991

RE:RE:RE:RE:RE:RE:PMED vs SONA

'The McGill study is for further validation at an academic level.'

'Further validation'? What validation do we have already? Deployment of machines is not validation IMHO. Could be for more testing?

Plus I'm not sure investors need validation at an academic level. What investors need is validation at the customer level. This comes with contracts and revenues. That is what tells us if the company has a proven product that others are willing to pay for....that is what would make it worth our investment.

Badog

<< Previous

Bullboard Posts

Next >>

Changing Europe’s dependency on HREE from China